1. Home
  2. DCGO vs PMVP Comparison

DCGO vs PMVP Comparison

Compare DCGO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.41

Market Cap

63.5M

Sector

Health Care

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.32

Market Cap

66.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
PMVP
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.5M
66.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
DCGO
PMVP
Price
$0.41
$1.32
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
734.8K
305.0K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$322,196,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$1.02
52 Week High
$1.73
$1.88

Technical Indicators

Market Signals
Indicator
DCGO
PMVP
Relative Strength Index (RSI) 31.80 60.30
Support Level N/A $1.04
Resistance Level $0.67 $1.49
Average True Range (ATR) 0.05 0.07
MACD -0.03 0.01
Stochastic Oscillator 2.66 95.16

Price Performance

Historical Comparison
DCGO
PMVP

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: